Novel Hematological Biomarkers Predict Survival in Renal Cell Carcinoma Patients Treated With Nephrectomy

Archives of Medical Science - Poland
doi 10.5114/aoms.2017.70250
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Pd41-11 Differences in Overall Survival for Patients With Stage I-Ii Renal Cell Carcinoma Treated With Partial or Radical Nephrectomy

Journal of Urology
Urology
2016English

Prognostic Values of Hematological Biomarkers in Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2018English

Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma

Urology
Urology
2008English

Mp28-09 Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma and Tumor Thrombus – Trends and Effect on Overall Survival

Journal of Urology
Urology
2018English

Gender-Related Differences in Surgically Treated Patients With Renal Cell Carcinoma

Journal of Urological Surgery
2018English

DNA Methylation Profiling Reveals Novel Diagnostic Biomarkers in Renal Cell Carcinoma

BMC Medicine
Medicine
2014English

Renal Leiomyosarcoma Treated With Partial Nephrectomy

Clinics
Medicine
2005English

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated With Sorafenib

Cancer Research
Cancer ResearchOncology
2018English

Histological Subtype of Renal Cell Carcinoma Significantly Affects Survival in the Era of Partial Nephrectomy

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy